Simon Moore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Simon Moore has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Abhinav Suri
Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif
2 shared publications - Andrew C. Vivas
Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA
2 shared publications - Anshul Ratnaparkhi
Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA
2 shared publications - Bayard Wilson
Department of Neurosurgery, University of California, Los Angeles, Los Angeles, California, USA
2 shared publications - David A. Zarrin
David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
2 shared publications - David Berin
Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
2 shared publications
Latest Publications
- Open Access
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e72535
The Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians
Background: Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. Objective: This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. Methods: The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. Results: Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. Conclusions: To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine.
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e72535
Open AccessThe Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians
Background: Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. Objective: This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. Methods: The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. Results: Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. Conclusions: To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine.
- 22 May 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (14) , 1561-1569
Litigation Patterns of Acute Compartment Syndrome
Background: Acute compartment syndrome (ACS) is a medical emergency and a cause of medical litigation across multiple specialties. We sought to compare the characteristics and outcomes of ACS-related litigation levied against surgeons in orthopaedics compared with other specialties. Methods: The Westlaw database was queried for ACS-related cases filed within the United States between 1980 and 2023 using the search term “compartment syndrome.” Inclusion criteria were defined as all jury verdicts or settlements tied to alleged medical malpractice concerning ACS of the spine and extremities. ACS cases of the abdomen were excluded. Results: Of 755 cases, 358 cases met inclusion criteria, 150 (42%) of which listed an orthopaedic surgeon as a defendant. A defendant verdict was reached in 203 cases (57%), a plaintiff verdict was reached in 88 cases (25%), and 67 cases (19%) were settled. The mean payout in orthopaedic cases was $3,219,519. Compared with non-orthopaedic practitioners, orthopaedic surgeons were significantly more likely to be named in cases in which ACS was due to surgery or fracture (both, p < 0.001) and in which the basis of litigation was alleged improper cast or splint application (p < 0.001). Orthopaedic surgeons were significantly less likely to be named in ACS cases when the basis of litigation was alleged negligent medication administration (p < 0.001). Only 3 cases (0.8%) mentioned documentation of compartment checks and intracompartmental pressures, and no cases were levied because of unnecessary fasciotomy. Two cases described the use of postoperative regional anesthesia for pain control. Conclusions: ACS-related litigation is associated with a considerable financial burden in the wake of substantial morbidity and mortality. Lawsuits against orthopaedic surgeons more commonly involve fractures and cast or splint application, whereas those against non-orthopaedists more commonly involve medication or fluid infiltration. Documentation of close monitoring for symptoms specifically related to ACS and intracompartmental pressure measures may be a valid method to mitigate associated medicolegal risk. Prophylactic fasciotomies have not historically been a source of litigation. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 22 May 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (14) , 1561-1569
Litigation Patterns of Acute Compartment Syndrome
Background: Acute compartment syndrome (ACS) is a medical emergency and a cause of medical litigation across multiple specialties. We sought to compare the characteristics and outcomes of ACS-related litigation levied against surgeons in orthopaedics compared with other specialties. Methods: The Westlaw database was queried for ACS-related cases filed within the United States between 1980 and 2023 using the search term “compartment syndrome.” Inclusion criteria were defined as all jury verdicts or settlements tied to alleged medical malpractice concerning ACS of the spine and extremities. ACS cases of the abdomen were excluded. Results: Of 755 cases, 358 cases met inclusion criteria, 150 (42%) of which listed an orthopaedic surgeon as a defendant. A defendant verdict was reached in 203 cases (57%), a plaintiff verdict was reached in 88 cases (25%), and 67 cases (19%) were settled. The mean payout in orthopaedic cases was $3,219,519. Compared with non-orthopaedic practitioners, orthopaedic surgeons were significantly more likely to be named in cases in which ACS was due to surgery or fracture (both, p < 0.001) and in which the basis of litigation was alleged improper cast or splint application (p < 0.001). Orthopaedic surgeons were significantly less likely to be named in ACS cases when the basis of litigation was alleged negligent medication administration (p < 0.001). Only 3 cases (0.8%) mentioned documentation of compartment checks and intracompartmental pressures, and no cases were levied because of unnecessary fasciotomy. Two cases described the use of postoperative regional anesthesia for pain control. Conclusions: ACS-related litigation is associated with a considerable financial burden in the wake of substantial morbidity and mortality. Lawsuits against orthopaedic surgeons more commonly involve fractures and cast or splint application, whereas those against non-orthopaedists more commonly involve medication or fluid infiltration. Documentation of close monitoring for symptoms specifically related to ACS and intracompartmental pressure measures may be a valid method to mitigate associated medicolegal risk. Prophylactic fasciotomies have not historically been a source of litigation. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 11 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
The Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians (Preprint)
BACKGROUND Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. OBJECTIVE This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. METHODS The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. RESULTS Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. CONCLUSIONS To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine. CLINICALTRIAL
- 11 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians (Preprint)
BACKGROUND Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. OBJECTIVE This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. METHODS The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. RESULTS Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. CONCLUSIONS To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine. CLINICALTRIAL